HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy.

Abstract
In this study, we report the case of a patient with profound lymphopenia after allogenic bone marrow transplantation who developed severe progressive multifocal leukoencephalopathy. Single-agent recombinant human interleukin-7 therapy was associated with restoration of anti-John Cunningham polyomavirus (JCV) T-cell responses, JCV clearance from cerebrospinal fluid, and a dramatic clinical improvement.
AuthorsJacques Gasnault, Marie-Ghislaine de Goër de Herve, Jean-Marie Michot, Houria Hendel-Chavez, Vannina Seta, Anne-Aurélie Mazet, Thérèse Croughs, Bruno Stankoff, Jean-Henri Bourhis, Olivier Lambotte, Jean-François Delfraissy, Yassine Taoufik
JournalOpen forum infectious diseases (Open Forum Infect Dis) Vol. 1 Issue 2 Pg. ofu074 (Sep 2014) ISSN: 2328-8957 [Print] United States
PMID25734144 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: